{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:32:58Z","timestamp":1780680778013,"version":"3.54.1"},"reference-count":61,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,2,16]],"date-time":"2005-02-16T00:00:00Z","timestamp":1108512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Die Dermatomyositis weist eine gro\u00dfe klinische Heterogenit\u00e4t auf. Es existieren eine Reihe von Klassifikationen, die sich auf die Beteiligung der Muskulatur, auf das Vorkommen von Autoantik\u00f6rpern und das Vorhandensein zus\u00e4tzlicher Symptome anderer Kollagenosen st\u00fctzen. \u00c4tiologisch wesentlich sind vorangegangene virale Infektionen, sowie das Entstehen von Tumoren, die auch erst nach Auftreten der Dermatomyositis klinisch manifest werden k\u00f6nnen. Genaue, auch wiederholte Untersuchungen sind daher bei diesen Patienten ratsam. Eine exakte Feststellung der Organbeteiligung, sowie die Charakterisierung bestimmter zirkulierender Antik\u00f6rper sind wichtige Voraussetzungen f\u00fcr das Erstellen einer Prognose f\u00fcr die Patienten. Die Dermatomyositis macht oft eine intensive, hochdosierte Therapie mit Glukokortikoiden, sowie immunsuppressiven Medikamenten oder Immunglobinen notwendig. Diese mu\u00df dem Verlauf der Erkrankung individuell angepa\u00dft sein.<\/jats:p>","DOI":"10.1111\/j.1610-0378.2005.05006.x","type":"journal-article","created":{"date-parts":[[2005,2,16]],"date-time":"2005-02-16T18:23:52Z","timestamp":1108578232000},"page":"181-194","source":"Crossref","is-referenced-by-count":11,"title":["Das klinische Spektrum der Dermatomyositis"],"prefix":"10.1111","volume":"3","author":[{"given":"Julia","family":"Kaufmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Hunzelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Genth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Krieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,2,16]]},"reference":[{"key":"e_1_2_13_2_2","first-page":"1300","article-title":"Elevated cancer incidence in patients with dermatomyositis: A population based study","volume":"22","author":"Airio A","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_13_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502132920706"},{"key":"e_1_2_13_4_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.21.13255"},{"key":"e_1_2_13_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05157-0"},{"key":"e_1_2_13_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb08492.x"},{"key":"e_1_2_13_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00051675"},{"key":"e_1_2_13_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.6_Suppl_5.S37"},{"key":"e_1_2_13_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)80765-7"},{"key":"e_1_2_13_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002560000238"},{"key":"e_1_2_13_11_2","unstructured":"GenthE. Autoantik\u00f6rper bei Dermato\u2010 und Polymyositiden in: Conrad K. (Ed): Autoantik\u00f6rper. Pabst Science Publishers Lengerich Berlin D\u00fcsseldorf Riga 1998; 303\u200a\u2013\u200a321."},{"key":"e_1_2_13_12_2","doi-asserted-by":"crossref","unstructured":"Genth. E. Entz\u00fcndliche Muskelerkrankungen aus internistischer Sicht. Internist 2000; 41 (5): 445\u200a\u2013\u200a454.","DOI":"10.1007\/s001080050537"},{"key":"e_1_2_13_13_2","first-page":"373","article-title":"Cardiac manifestations in dermato\u2010polymyositis","volume":"14","author":"Gonzalez\u2010Lopez L","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_13_14_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.171.3.819"},{"key":"e_1_2_13_15_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.4.2315"},{"key":"e_1_2_13_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70263-4"},{"key":"e_1_2_13_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199111000-00002"},{"key":"e_1_2_13_18_2","first-page":"1336","article-title":"Pulmonary involvement in polymyositis and in dermatomyositis","volume":"25","author":"Marie I","year":"1998","journal-title":"J Rheumatol"},{"key":"e_1_2_13_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390521"},{"key":"e_1_2_13_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114461"},{"key":"e_1_2_13_21_2","first-page":"91","article-title":"Morphologische und funktionelle Ver\u00e4nderungen an Nagelfalzkapillaren bei Dermatomyositis","volume":"20","author":"Patheiger U","year":"1991","journal-title":"Phlebol"},{"key":"e_1_2_13_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1995.01890110072013"},{"key":"e_1_2_13_23_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-9-199505010-00010"},{"key":"e_1_2_13_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202063260602"},{"key":"e_1_2_13_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199811000-00008"},{"key":"e_1_2_13_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199902)42:2<291::AID-ANR11>3.0.CO;2-1"},{"key":"e_1_2_13_27_2","first-page":"1991","article-title":"Scleroderma\u2010polymyositis overlap syndrome associated with anti\u2010KU antibody and rimmed vacuole formation","volume":"23","author":"Yamanishi Y","year":"1996","journal-title":"J Rheumatol"},{"key":"e_1_2_13_28_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-8-199704150-00003"},{"key":"e_1_2_13_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(02)00021-2"},{"key":"e_1_2_13_30_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-41136"},{"key":"e_1_2_13_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10313"},{"key":"e_1_2_13_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14368-1"},{"key":"e_1_2_13_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04587-6"},{"key":"e_1_2_13_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03535-2"},{"key":"e_1_2_13_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14862-3"},{"key":"e_1_2_13_36_2","first-page":"434","article-title":"Idiopathic Inflammatory Myopathy: Autoantibody Update","volume":"4","author":"Targoff IN","year":"2002","journal-title":"Opin Rheum"},{"key":"e_1_2_13_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(70)80006-7"},{"key":"e_1_2_13_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(02)00021-9"},{"key":"e_1_2_13_39_2","doi-asserted-by":"publisher","DOI":"10.1191\/0961203302lu186oa"},{"key":"e_1_2_13_40_2","doi-asserted-by":"crossref","unstructured":"RosenbergNL CarryMR RingelSP.Association of inflammatory myopathies with other connective tissue disorder and malignancies. In: Dalakas MC ed. Polymyositis and dermatomyositis. Boston:Butterworth 1988:37\u200a\u2013\u200a69.","DOI":"10.1016\/B978-0-409-95191-2.50007-0"},{"key":"e_1_2_13_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.7.969"},{"key":"e_1_2_13_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(02)00030-3"},{"key":"e_1_2_13_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199711000-00007"},{"key":"e_1_2_13_44_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2990.1998.00092.x"},{"key":"e_1_2_13_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004010000207"},{"key":"e_1_2_13_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-000-0082-y"},{"key":"e_1_2_13_47_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200022060-00003"},{"key":"e_1_2_13_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200010000-00006"},{"key":"e_1_2_13_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)61628-5"},{"key":"e_1_2_13_50_2","first-page":"752","article-title":"Myositis following treatment with high\u2010dose interleukin\u20102 for malignancy","volume":"4","author":"Finger DR","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_13_51_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.33.806"},{"key":"e_1_2_13_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(01)00478-6"},{"key":"e_1_2_13_53_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199205213262102"},{"key":"e_1_2_13_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199807)41:7<1215::AID-ART11>3.0.CO;2-Y"},{"key":"e_1_2_13_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100670070030"},{"key":"e_1_2_13_56_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.74"},{"key":"e_1_2_13_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1568-9972(02)00086-1"},{"key":"e_1_2_13_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200004000-00005"},{"key":"e_1_2_13_59_2","first-page":"668","article-title":"Classification criteria for polymyositis and dermatomyositis","volume":"22","author":"Tanimoto K","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_13_60_2","first-page":"241","article-title":"Features of polymyositis and dermatomyositis in the elderly: a case\u2010control study","volume":"18","author":"Pautas E","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_13_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.1.22"},{"key":"e_1_2_13_62_2","doi-asserted-by":"crossref","unstructured":"Hengstman GJ van den Hoogen FH Barrera P Netea MG Pieterse A van de Putte LB van Engelen BG. Successful treatment of dermatomyositis and polymyositis with anti\u2010tumor\u2010necrosis\u2010factor\u2010alpha: preliminary observations. Eur Neurol 2003; 50: 10\u200a\u2013\u200a15.y.","DOI":"10.1159\/000070852"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1610-0378.2005.05006.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1610-0378.2005.05006.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T01:47:43Z","timestamp":1697075263000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1610-0378.2005.05006.x"}},"subtitle":["The clinical spectrum of dermatomyositis"],"short-title":[],"issued":{"date-parts":[[2005,2,16]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1111\/j.1610-0378.2005.05006.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1610-0378.2005.05006.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,16]]}}}